Strive Health Raises $550 Million to Scale AI-Enabled Kidney Care
The company cites proven results, nationwide reach, certified technology to propel expansion.
Overview
- The financing combines a $300 million Series D equity round led by New Enterprise Associates with $250 million in debt led by Hercules Capital.
- Additional equity participants include CVS Health Ventures, CapitalG, Echo Health Ventures, Town Hall Ventures, Redpoint, and funds managed by BlackRock affiliates.
- Strive plans to expand partnerships with payers and providers, grow multi‑specialty services, and advance AI and analytics within its CareMultiplier platform.
- The company reports partnerships with more than 6,500 providers across all 50 states, managing nearly $5 billion in annual medical spend for over 145,000 people.
- Strive cites a 20% reduction in total kidney care costs, a 41% drop in hospitalizations, and 94% patient satisfaction, with HITRUST certification and NCQA program accreditations supporting its model.